SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-24-071413
Filing Date
2024-03-19
Accepted
2024-03-19 16:44:47
Documents
4
Group Members
XRA 1 CORP.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d649624dsctota.htm SC TO-T/A 43814
2 EX-99.(A)(1)(A) d649624dex99a1a.htm EX-99.A1A 454174
3 EX-99.(A)(5)(C) d649624dex99a5c.htm EX-99.A5C 16305
4 GRAPHIC g649624g0320000923963.jpg GRAPHIC 6062
  Complete submission text file 0001193125-24-071413.txt   524636
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filed by) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Subject) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-91893 | Film No.: 24764141
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)